<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Sat, 04 Apr 2026 21:20:32 -0400--><rss version="2.0">
    <channel>
        <title>Tonix Pharmaceuticals Holding Corp. (TNXP) Press Releases</title>
        <link>https://ir.tonixpharma.com/news-events/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://s3.amazonaws.com/equisolve-dev4/tonixpharma/files/theme/images/logo-sm.png</url>
                <title>Tonix Pharmaceuticals Holding Corp. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.tonixpharma.com/news-events/press-releases/detail/1621/tonix-pharmaceuticals-announces-presentation-of-phase-1</link>
                <pubDate>Tue, 31 Mar 26 07:00:00 -0400</pubDate>
                <guid>https://ir.tonixpharma.com/news-events/press-releases/detail/1621/tonix-pharmaceuticals-announces-presentation-of-phase-1</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and Craniofacial Pain]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.tonixpharma.com/news-events/press-releases/detail/1620/tonix-pharmaceuticals-announces-first-participant-dosed-in</link>
                <pubDate>Thu, 26 Mar 26 07:00:00 -0400</pubDate>
                <guid>https://ir.tonixpharma.com/news-events/press-releases/detail/1620/tonix-pharmaceuticals-announces-first-participant-dosed-in</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.tonixpharma.com/news-events/press-releases/detail/1619/tonix-pharmaceuticals-announces-presentations-at-world</link>
                <pubDate>Mon, 23 Mar 26 16:32:00 -0400</pubDate>
                <guid>https://ir.tonixpharma.com/news-events/press-releases/detail/1619/tonix-pharmaceuticals-announces-presentations-at-world</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Tonix Pharmaceuticals to Present at BIO-Europe Spring 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.tonixpharma.com/news-events/press-releases/detail/1618/tonix-pharmaceuticals-to-present-at-bio-europe-spring-2026</link>
                <pubDate>Wed, 18 Mar 26 16:58:00 -0400</pubDate>
                <guid>https://ir.tonixpharma.com/news-events/press-releases/detail/1618/tonix-pharmaceuticals-to-present-at-bio-europe-spring-2026</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.tonixpharma.com/news-events/press-releases/detail/1617/tonix-pharmaceuticals-announces-oral-presentation-and-two</link>
                <pubDate>Tue, 17 Mar 26 16:35:00 -0400</pubDate>
                <guid>https://ir.tonixpharma.com/news-events/press-releases/detail/1617/tonix-pharmaceuticals-announces-oral-presentation-and-two</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.tonixpharma.com/news-events/press-releases/detail/1616/tonix-pharmaceuticals-reports-fourth-quarter-and-full-year</link>
                <pubDate>Thu, 12 Mar 26 17:30:00 -0400</pubDate>
                <guid>https://ir.tonixpharma.com/news-events/press-releases/detail/1616/tonix-pharmaceuticals-reports-fourth-quarter-and-full-year</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Tonix Pharmaceuticals Presented Post Hoc Analyses of Phase 3 Data on TONMYA™ at the 8th International Congress on Controversies in Fibromyalgia]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.tonixpharma.com/news-events/press-releases/detail/1615/tonix-pharmaceuticals-presented-post-hoc-analyses-of-phase</link>
                <pubDate>Tue, 10 Mar 26 08:00:00 -0400</pubDate>
                <guid>https://ir.tonixpharma.com/news-events/press-releases/detail/1615/tonix-pharmaceuticals-presented-post-hoc-analyses-of-phase</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Tonix Pharmaceuticals Presented Data on TONMYA™ in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.tonixpharma.com/news-events/press-releases/detail/1614/tonix-pharmaceuticals-presented-data-on-tonmya-in</link>
                <pubDate>Mon, 09 Mar 26 16:30:00 -0400</pubDate>
                <guid>https://ir.tonixpharma.com/news-events/press-releases/detail/1614/tonix-pharmaceuticals-presented-data-on-tonmya-in</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.tonixpharma.com/news-events/press-releases/detail/1613/tonix-pharmaceuticals-announces-publication-of-clinical</link>
                <pubDate>Thu, 05 Mar 26 16:15:00 -0500</pubDate>
                <guid>https://ir.tonixpharma.com/news-events/press-releases/detail/1613/tonix-pharmaceuticals-announces-publication-of-clinical</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2026 American Academy of Pain Medicine PainConnect Annual Meeting]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.tonixpharma.com/news-events/press-releases/detail/1612/tonix-pharmaceuticals-to-present-poster-on-tonmya-at-the</link>
                <pubDate>Tue, 03 Mar 26 16:30:00 -0500</pubDate>
                <guid>https://ir.tonixpharma.com/news-events/press-releases/detail/1612/tonix-pharmaceuticals-to-present-poster-on-tonmya-at-the</guid>
                                                                            </item>
            </channel>
</rss>